147 related articles for article (PubMed ID: 37933882)
21. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
[TBL] [Abstract][Full Text] [Related]
22. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.
Ehrlich PF; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Tornwall B; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Dome JS
Cancer; 2020 Aug; 126(15):3516-3525. PubMed ID: 32459384
[TBL] [Abstract][Full Text] [Related]
23. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).
Chintagumpala MM; Perlman EJ; Tornwall B; Chi YY; Kim Y; Hoffer FA; Kalapurakal JA; Warwick AB; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Fernandez CV; Ritchey ML; Grundy PE; Dome JS; Ehrlich PF
Cancer; 2022 Jul; 128(13):2493-2503. PubMed ID: 35383900
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
[TBL] [Abstract][Full Text] [Related]
25. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
[TBL] [Abstract][Full Text] [Related]
26. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Macklis R; Thomas PR; D'Angio GJ; Kim T; de Lorimier A; Kelalis P; Shochat S; Ritchey M; Haase G; Hrabovsky E; Otherson HB; Grundy P; Green DM;
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):495-9. PubMed ID: 12957262
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor.
Pachnis A; Pritchard J; Gaze M; Levitt G; Michalski A
Med Pediatr Oncol; 1998 Sep; 31(3):150-2. PubMed ID: 9722896
[TBL] [Abstract][Full Text] [Related]
28. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
Seibel NL; Chi YY; Perlman EJ; Tian J; Sun J; Anderson JR; Ritchey ML; Thomas PR; Miser J; Kalapurakal JA; Grundy PE; Green DM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27450. PubMed ID: 30255545
[TBL] [Abstract][Full Text] [Related]
29. Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group.
Ritchey ML; Shamberger RC; Haase G; Horwitz J; Bergemann T; Breslow NE
J Am Coll Surg; 2001 Jan; 192(1):63-8; quiz 146. PubMed ID: 11192924
[TBL] [Abstract][Full Text] [Related]
30. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
[TBL] [Abstract][Full Text] [Related]
31. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study.
Corn BW; Goldwein JW; Evans I; D'Angio GJ
J Clin Oncol; 1992 Aug; 10(8):1305-9. PubMed ID: 1321894
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.
Madanat-Harjuoja LM; Renfro LA; Klega K; Tornwall B; Thorner AR; Nag A; Dix D; Dome JS; Diller LR; Fernandez CV; Mullen EA; Crompton BD
J Clin Oncol; 2022 Sep; 40(26):3047-3056. PubMed ID: 35580298
[TBL] [Abstract][Full Text] [Related]
33. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group.
Ehrlich P; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Ritchey ML; Dome JS
Ann Surg; 2017 Sep; 266(3):470-478. PubMed ID: 28795993
[TBL] [Abstract][Full Text] [Related]
34. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.
Daw NC; Chi YY; Kalapurakal JA; Kim Y; Hoffer FA; Geller JI; Perlman EJ; Ehrlich PF; Mullen EA; Warwick AB; Grundy PE; Paulino AC; Gratias E; Ward D; Anderson JR; Khanna G; Tornwall B; Fernandez CV; Dome JS;
J Clin Oncol; 2020 May; 38(14):1558-1568. PubMed ID: 32134700
[TBL] [Abstract][Full Text] [Related]
35. Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group.
Meisel JA; Guthrie KA; Breslow NE; Donaldson SS; Green DM
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):579-85. PubMed ID: 10348287
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.
Grundy PE; Green DM; Dirks AC; Berendt AE; Breslow NE; Anderson JR; Dome JS
Pediatr Blood Cancer; 2012 Oct; 59(4):631-5. PubMed ID: 22422736
[TBL] [Abstract][Full Text] [Related]
37. Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534.
Ehrlich PF; Tornwall B; Chintagumpala MM; Chi YY; Hoffer FA; Perlman EJ; Kalapurakal JA; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Fernandez CV; Dome JS
Ann Surg Oncol; 2022 May; 29(5):3252-3261. PubMed ID: 35072864
[TBL] [Abstract][Full Text] [Related]
38. Ureteral extension in Wilms' tumor: a report from the National Wilms' Tumor Study Group (NWTSG).
Ritchey M; Daley S; Shamberger RC; Ehrlich P; Hamilton T; Haase G; Sawin R;
J Pediatr Surg; 2008 Sep; 43(9):1625-9. PubMed ID: 18778996
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group.
Porteus MH; Narkool P; Neuberg D; Guthrie K; Breslow N; Green DM; Diller L
J Clin Oncol; 2000 May; 18(10):2026-31. PubMed ID: 10811666
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.
Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; Thomas PR; Grundy P; Green DM; D'Angio GJ
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):201-6. PubMed ID: 19395185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
